Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury

Valeria Sasso, Elisa Bisicchia, Laura Latini, Veronica Ghiglieri, Fabrizio Cacace, Valeria Carola, Marco Molinari, Maria Teresa Viscomi

Research output: Contribution to journalArticle

Abstract

Background: After focal brain injuries occur, in addition to the effects that are attributable to the primary site of damage, the resulting functional impairments depend highly on changes that occur in regions that are remote but functionally connected to the site of injury. Such effects are associated with apoptotic and inflammatory cascades and are considered to be important predictors of outcome. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive technique that is used to treat various central nervous system (CNS) pathologies and enhance functional recovery after brain damage. Objective: This study examined the efficacy of rTMS in mitigating remote degeneration and inflammation and in improving functional recovery in a model of focal brain damage. Methods: Rats that were undergoing hemicerebellectomy (HCb) were treated with an rTMS protocol for 7 days, and neuronal death indices, glial activation, and functional recovery were assessed. Results: rTMS significantly reduced neuronal death and glial activation in remote regions and improved functional recovery. Conclusions: Our finding opens up a completely new scenario for exploiting the potential of rTMS as an anti-apoptotic and anti-inflammatory treatment.

Original languageEnglish
Article number150
JournalJournal of Neuroinflammation
Volume13
Issue number1
DOIs
Publication statusPublished - Jun 14 2016

Fingerprint

Transcranial Magnetic Stimulation
Brain Injuries
Cell Death
Inflammation
Neuroglia
Brain
Anti-Inflammatory Agents
Central Nervous System
Pathology
Wounds and Injuries

Keywords

  • Apoptosis
  • Glial activation
  • Inflammation
  • Neuroprotection
  • Remote degeneration
  • Transcranial magnetic stimulation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Cellular and Molecular Neuroscience
  • Neurology
  • Immunology

Cite this

Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury. / Sasso, Valeria; Bisicchia, Elisa; Latini, Laura; Ghiglieri, Veronica; Cacace, Fabrizio; Carola, Valeria; Molinari, Marco; Viscomi, Maria Teresa.

In: Journal of Neuroinflammation, Vol. 13, No. 1, 150, 14.06.2016.

Research output: Contribution to journalArticle

Sasso, Valeria ; Bisicchia, Elisa ; Latini, Laura ; Ghiglieri, Veronica ; Cacace, Fabrizio ; Carola, Valeria ; Molinari, Marco ; Viscomi, Maria Teresa. / Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury. In: Journal of Neuroinflammation. 2016 ; Vol. 13, No. 1.
@article{95ccc204cb42416db337ac154404f796,
title = "Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury",
abstract = "Background: After focal brain injuries occur, in addition to the effects that are attributable to the primary site of damage, the resulting functional impairments depend highly on changes that occur in regions that are remote but functionally connected to the site of injury. Such effects are associated with apoptotic and inflammatory cascades and are considered to be important predictors of outcome. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive technique that is used to treat various central nervous system (CNS) pathologies and enhance functional recovery after brain damage. Objective: This study examined the efficacy of rTMS in mitigating remote degeneration and inflammation and in improving functional recovery in a model of focal brain damage. Methods: Rats that were undergoing hemicerebellectomy (HCb) were treated with an rTMS protocol for 7 days, and neuronal death indices, glial activation, and functional recovery were assessed. Results: rTMS significantly reduced neuronal death and glial activation in remote regions and improved functional recovery. Conclusions: Our finding opens up a completely new scenario for exploiting the potential of rTMS as an anti-apoptotic and anti-inflammatory treatment.",
keywords = "Apoptosis, Glial activation, Inflammation, Neuroprotection, Remote degeneration, Transcranial magnetic stimulation",
author = "Valeria Sasso and Elisa Bisicchia and Laura Latini and Veronica Ghiglieri and Fabrizio Cacace and Valeria Carola and Marco Molinari and Viscomi, {Maria Teresa}",
year = "2016",
month = "6",
day = "14",
doi = "10.1186/s12974-016-0616-5",
language = "English",
volume = "13",
journal = "Journal of Neuroinflammation",
issn = "1742-2094",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury

AU - Sasso, Valeria

AU - Bisicchia, Elisa

AU - Latini, Laura

AU - Ghiglieri, Veronica

AU - Cacace, Fabrizio

AU - Carola, Valeria

AU - Molinari, Marco

AU - Viscomi, Maria Teresa

PY - 2016/6/14

Y1 - 2016/6/14

N2 - Background: After focal brain injuries occur, in addition to the effects that are attributable to the primary site of damage, the resulting functional impairments depend highly on changes that occur in regions that are remote but functionally connected to the site of injury. Such effects are associated with apoptotic and inflammatory cascades and are considered to be important predictors of outcome. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive technique that is used to treat various central nervous system (CNS) pathologies and enhance functional recovery after brain damage. Objective: This study examined the efficacy of rTMS in mitigating remote degeneration and inflammation and in improving functional recovery in a model of focal brain damage. Methods: Rats that were undergoing hemicerebellectomy (HCb) were treated with an rTMS protocol for 7 days, and neuronal death indices, glial activation, and functional recovery were assessed. Results: rTMS significantly reduced neuronal death and glial activation in remote regions and improved functional recovery. Conclusions: Our finding opens up a completely new scenario for exploiting the potential of rTMS as an anti-apoptotic and anti-inflammatory treatment.

AB - Background: After focal brain injuries occur, in addition to the effects that are attributable to the primary site of damage, the resulting functional impairments depend highly on changes that occur in regions that are remote but functionally connected to the site of injury. Such effects are associated with apoptotic and inflammatory cascades and are considered to be important predictors of outcome. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive technique that is used to treat various central nervous system (CNS) pathologies and enhance functional recovery after brain damage. Objective: This study examined the efficacy of rTMS in mitigating remote degeneration and inflammation and in improving functional recovery in a model of focal brain damage. Methods: Rats that were undergoing hemicerebellectomy (HCb) were treated with an rTMS protocol for 7 days, and neuronal death indices, glial activation, and functional recovery were assessed. Results: rTMS significantly reduced neuronal death and glial activation in remote regions and improved functional recovery. Conclusions: Our finding opens up a completely new scenario for exploiting the potential of rTMS as an anti-apoptotic and anti-inflammatory treatment.

KW - Apoptosis

KW - Glial activation

KW - Inflammation

KW - Neuroprotection

KW - Remote degeneration

KW - Transcranial magnetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=84974808963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974808963&partnerID=8YFLogxK

U2 - 10.1186/s12974-016-0616-5

DO - 10.1186/s12974-016-0616-5

M3 - Article

AN - SCOPUS:84974808963

VL - 13

JO - Journal of Neuroinflammation

JF - Journal of Neuroinflammation

SN - 1742-2094

IS - 1

M1 - 150

ER -